ICRP Symposium on the International System of Radiological Protection October 24-26, 2011 Bethesda, MD, USA Günther Dietze ICRP Committee 2
Members of ICRP ask Group 67 D.. Bartlett (UK) Comm. 2 D. A. Cool (US) Comm. 4 F. A. Cucinotta (US) G. Dietze (DE), (chair) Comm. 2 J. Xianghong (CH) I. McAulay (IR) M. Pelliccioni (I) V. Petrov (RU) G. Reitz (DE). Sato (JP) 2
Assessment of radiation exposure of astronauts in space Special situation for astronauts in space extraordinary radiation field (high energies etc.) specific environment with limited protection possibilities only external radiation exposure few number of astronauts are involved only but high doses during missions (0.4-0.7 msv/d) strong interest in risk values of detriment risk of deterministic effects 3
Assessment of radiation exposure of astronauts in space Components of the radiation field in space galactic cosmic radiation (GCR) (protons, a-particles, heavy ions) solar cosmic particles (low energy electrons and protons) solar particle events (SPE) (electrons, protons, photons) earth albedo (electrons, protons, neutrons) secondary radiation in a spacecraft (photons, electrons, neutrons, charged particles) 4
Relative ion distribution of the galactic cosmic radiation (GCR) H C-12 Fe-56 Number of tracks for the same absorbed dose in soft tissue Protons 1000 C-12 13 Fe-56 1.3 (Cucinotta et al., 2001) Mean absorbed dose, D? 5
GCR fluence spectra at 380 km height (calculated with creme96/creme03) 10-2 Fluence rate in MeV -1 cm -2 s -1 10-3 10-4 10-5 10-6 10-7 10-8 10-9 10-10 10 0 10 1 10 2 10 3 10 4 10 5 10 6 Particle Energy in MeV/u (Sato et al., 2010)
Relative cosmic ray fluence rate in % Relative cosmic ray fluence rate variation with time In the solar cycle of the heliocentric potential +10 + 5 0-5 -10-15 -20-25 -30-35 1960 1970 1980 1990 2000 2010 Year (http://www.nmdb.eu/?q=node/138)
p >100 MeV F p >80 MeV F p >30 MeV in F cm -2 p >30 MeV in cm -2 F p >100 MeV F p >80 MeV 10 11 10 10 10 9 10 8 10 7 10 10 10 9 10 8 Integral proton fluence (E p > 30 MeV, 100 MeV) of various solar particle events Cycle 19 Cycle 20 20 Cycle 21 21 Cycle 22 22 Cycle 23 23 10 7 Cycle 19 20 21 22 23 Date (Myung-Hee et al., 2011) 8
Neutron spectra measured with Bonner sphere spectrometer at different heights above ground 1.5 56g/cm 2 (20km) 10g/cm 2 (16km) Neutrons from evaporation Ed N/dE(cm -2 sec -1 ) 1.0 0.5 20g/cm 2 (12km) x2.9 1030g/cm 2 (0km) onground x813 FluenceRateperLethargy Neutrons from proton collisions 0.0 10-8 10-6 10-4 10-2 1 0 10 2 10 4 NeutronEnergy(MeV) (Goldhagen al., 2002) 9
Particles fluence rates in trapped radiation zones protons > 34 MeV and electrons > 0.5 MeV Earth radius Proton belts E > 34 MeV (up to 700 MeV) Electron belts E > 0.5 MeV (up to 7 MeV) 10
M M D w H R F F D w H R Equivalent dose in an organ or tissue (ICRP 103) Organ dose equivalent (ESA, NASA, ; NCRP ) m L m L L D L Q m D Q H d )d ( ) ( 1 M M M m L m L L D L Q m D Q H d )d ( ) ( 1 F F F H H??? Mean weighted absorbed dose in an organ or tissue ) ( 0.5 F M H H E A single w R -value for each particle type except neutrons
Human body averaged mean quality factors, Q ISO for ISO exposure to GCR (data from Sato et al., 2009) Q ISO w R Q ISO w w Q D D (Sato et al., 2010)
Bone marrow Breast Colon Lung Stomach Gonads Liver Oesophagus hyroid Bladder Bone surface Brain Salivary Skin Remainder Equivalent dose and organ dose equivalent from the GCR C-12 component (ISO exposure) 5.00E+03 psv 4.00E+03 C-12 equivalent dose dose equivalent 3.00E+03 2.00E+03 1.00E+03 0.00E+00 (Sato et al., 2010)
Bone marrow Breast Colon Lung Stomach Gonads Liver Oesophagus hyroid Bladder Bone surface Brain Salivary Skin Remainder Equivalent dose and organ dose equivalent from the GCR Fe-56 component (ISO exposure) 9.00E+03 8.00E+03 psv 7.00E+03 6.00E+03 5.00E+03 4.00E+03 3.00E+03 2.00E+03 1.00E+03 Fe-56 equivalent dose dose equivalent 0.00E+00 (Sato et al., 2010)
Effective dose and effective dose equivalent rate for ISO exposure to galactic cosmic radiation (GCR) (data from Sato et al., 2009) 1000.0000 effective dose, effective dose equivalent rate 10 3 10 2 100.0000 10 1 10.0000 10 0 1.0000 10-1 0.1000 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 Z (Sato et al., 2010) 15
Radiation weighting for neutrons w R (ICRP 60) w R (ICRP 103) q E (Sato et al., 2009)
Assessment of radiation exposure of astronauts in space Measurements Area monitoring (inside and outside of a space vehicle) provide information about the radiation field provide monitoring and warning capabilities Individual monitoring assessment of organ and tissue doses and effective dose equivalent Biodosimetry investigation of lymphocytes in blood samples (problem of individual response and background) 17
Area monitoring in space Area monitoring: particle spectra, fluence rates, LE distributions development of special instrumentation for use in space, but mostly using concepts also applied in dosimetry on Earth. Active devices can provide real-time access and warning capabilities issue-equivalent proportional counters D, D(L), LE-distributions., mean Q, H (for all types of particles) Semiconductor devices Silicon diodes, multi-detector telescopes charged particle energies and charges, LE-values and doses, directions of radiation incidence Specific electron detectors (for electrons < 1 MeV) 18
Individual monitoring in space Individual monitoring: assessment of individual exposure (risk assesment) and doses for the records special devices measuring dose, LE, particle charges or specific particles only. Active devices usually develloped for electron, photon and neutron fields can provide real-time access and warning capabilities issue-equivalent proportional counters (D, D, LE-distr., mean Q, H) (for all types of particles) hermoluminescence and optically stimulated luminescence detectors Nuclear track detectors Superheated bubble detectors Combined detector systems 19
Combined detector system of thermoluminescence (LD) and etched-track detector (ED) Detector response 1 ideal LD actual 1 actual ED ideal 0 LE 0 LE 10 kev/mm 10 kev/mm H D DL LD D LD dl D ED Q( L)dL ED L>10 kevmm L>10 kevmm L<10 kevmm D ED dl 20
Human Phantom - MAROSHKA 2004-2010 Some Missions at the ISS HAMLE Project DLR Deutsches Zentrum für Luft und Raumfahrt e.v. G. Reitz Phantom torso + Poncho + Container outside ISS in space
Biological dosimetry with astronauts Mission doses of astronauts obtained by biological dosimetry and compared to results from measurements with individual dosemeters (LD) (Looking at total chromosomal exchanges, Cucinotta et al., 2008) Biolog. Dose, RBED in mgy Individual population based calibration Individual dosem. reading Skin dose equivalent Effective dose equivalent mgy msv msv 19 Astronauts 10-134 15-130 20-36 56-115 47-99 Mean value 85 81 28,9 83,8 71,9 While the mean values agree very well, the variation and discrepancies of individual doses are large. 22
Assessment of Radiation Exposure to Astronauts in Space Conclusions (1) he primary radiation field in space with many charged particle types and very high energies needs to be well known as a basis for a radiological protection concept and particle transport calculations. Depending on time and position in a spacecraft the radiation field varies considerably and needs active radiation monitoring. he relatively low number of astronauts involved in space missions and the risk of higher doses to be achieved needs a more individually based dose assessment than usual on Earth. For planning of missions in space individual risk assessment is as important as individual dose assessment which is needed for dose recording. he high contribution of various heavy ions to the exposure in space is not sufficiently reflected by applying a single radiation weighting factor w R = 20 23
Assessment of Radiation Exposure to Astronauts in Space Conclusions (2) An assessment of doses to astronauts in space needs both measurements with multidetector systems and radiation transport calculations. Specific instrumentation is needed for separately assessing the dose from low-penetrating radiation. If the dose component from low-penetrating radiation can be separately determined the measurement of the skin dose or dose near the surface of the body may be appropriate for the assessment of effective dose or organ doses. Missions outside of a spacecraft needs careful consideration of the lowenergy electron and proton components for avoiding high exposures of the skin and the lens of the eye. 24
www.icrp.org